BR112020005849A8 - Partículas sólidas de simeticona e forma de dosagem das mesmas - Google Patents

Partículas sólidas de simeticona e forma de dosagem das mesmas

Info

Publication number
BR112020005849A8
BR112020005849A8 BR112020005849A BR112020005849A BR112020005849A8 BR 112020005849 A8 BR112020005849 A8 BR 112020005849A8 BR 112020005849 A BR112020005849 A BR 112020005849A BR 112020005849 A BR112020005849 A BR 112020005849A BR 112020005849 A8 BR112020005849 A8 BR 112020005849A8
Authority
BR
Brazil
Prior art keywords
dosage form
simethicone
solid particles
simethicone solid
particle
Prior art date
Application number
BR112020005849A
Other languages
English (en)
Other versions
BR112020005849A2 (pt
Inventor
P Mcnally Gerard
Szymczak Christopher
Original Assignee
Currahee Holding Company Inc
Johnson & Johnson Consumer Inc
Chenango Zero Llc
Chenango Two Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Currahee Holding Company Inc, Johnson & Johnson Consumer Inc, Chenango Zero Llc, Chenango Two Llc filed Critical Currahee Holding Company Inc
Publication of BR112020005849A2 publication Critical patent/BR112020005849A2/pt
Publication of BR112020005849A8 publication Critical patent/BR112020005849A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A presente invenção refere-se a partículas de simeticona microencapsulada contendo simeticona e um revestimento solúvel em água, em que a simeticona é cerca de 50%, em peso da partícula.
BR112020005849A 2017-09-29 2018-09-14 Partículas sólidas de simeticona e forma de dosagem das mesmas BR112020005849A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762565850P 2017-09-29 2017-09-29
US62/565,850 2017-09-29
PCT/IB2018/057057 WO2019064112A1 (en) 2017-09-29 2018-09-14 SOLID PARTICLES OF SIMETHICONE AND THEIR DOSAGE FORM

Publications (2)

Publication Number Publication Date
BR112020005849A2 BR112020005849A2 (pt) 2020-10-06
BR112020005849A8 true BR112020005849A8 (pt) 2022-07-26

Family

ID=63713965

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020005849A BR112020005849A8 (pt) 2017-09-29 2018-09-14 Partículas sólidas de simeticona e forma de dosagem das mesmas

Country Status (11)

Country Link
US (1) US10722472B2 (pt)
EP (2) EP3687502B1 (pt)
JP (1) JP7282753B2 (pt)
KR (1) KR102648960B1 (pt)
CN (1) CN111132667A (pt)
AU (1) AU2018343214B2 (pt)
BR (1) BR112020005849A8 (pt)
CA (1) CA3076413A1 (pt)
MX (1) MX2020003761A (pt)
PH (1) PH12020550113A1 (pt)
WO (1) WO2019064112A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111389318B (zh) * 2020-04-17 2020-11-10 南京鼓楼医院 一种具备分子筛效应的互穿网络微胶囊制备方法
WO2022118107A1 (en) * 2020-12-03 2022-06-09 Johnson & Johnson Consumer Inc. Multi-layered particle comprising simethicone
CN113293129B (zh) * 2021-03-29 2022-06-17 浙江大学舟山海洋研究中心 一种促进成骨前体细胞增殖的功能肽混合粉及其应用
GB2615103A (en) * 2022-01-27 2023-08-02 Anabio Tech Limited A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002332B (el) 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
CA2378889C (en) * 1999-07-20 2006-07-04 The Procter & Gamble Company Improved encapsulated oil particles
US6100245A (en) 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
CN1288730A (zh) 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US6676933B2 (en) * 2001-05-23 2004-01-13 Osmotica Corp. Pharmaceutical composition containing mosapride and pancreatin
US7101573B2 (en) 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
MXPA06010972A (es) * 2006-09-25 2009-04-17 World Trade Imp Export Wtie Ag Proceso para estabilizacion de famotidina.
WO2008056200A1 (en) 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone
WO2011039768A2 (en) * 2009-09-17 2011-04-07 Cadila Healthcare Limited Pharmaceutical compositions for reducing alcohol-induced dose dumping

Also Published As

Publication number Publication date
JP2020535200A (ja) 2020-12-03
CA3076413A1 (en) 2019-04-04
KR20200061386A (ko) 2020-06-02
BR112020005849A2 (pt) 2020-10-06
AU2018343214B2 (en) 2023-10-05
CN111132667A (zh) 2020-05-08
EP3687502A1 (en) 2020-08-05
EP3687502C0 (en) 2023-06-07
US20190099379A1 (en) 2019-04-04
MX2020003761A (es) 2020-07-29
RU2020114918A3 (pt) 2022-04-19
WO2019064112A1 (en) 2019-04-04
JP7282753B2 (ja) 2023-05-29
EP4215187A1 (en) 2023-07-26
RU2020114918A (ru) 2021-10-29
EP3687502B1 (en) 2023-06-07
PH12020550113A1 (en) 2020-12-07
AU2018343214A1 (en) 2020-03-26
US10722472B2 (en) 2020-07-28
KR102648960B1 (ko) 2024-03-20

Similar Documents

Publication Publication Date Title
BR112020005849A8 (pt) Partículas sólidas de simeticona e forma de dosagem das mesmas
BR112017017217A2 (pt) ?composição que compreende ramnolipídeo e siloxano?
BR112016023676A2 (pt) pó de sinterização com baixa pressão
BR112015022417A2 (pt) métodos e composições para inibição de proteínas contendo bromodomínio
GT201400215A (es) Compuestos de indol e indazol que activan la ampk
BR112018011216A2 (pt) métodos para inibir a conversão de colina em trimetilamina (tma)
BR112018004464A2 (pt) membro deslizante de baixa fricção
BR112013004889A8 (pt) composição de proteção de superfície sem fluoropolímero
PH12019501178A1 (en) Thiopene derivatives as antiviral agents
BR112019008463A2 (pt) composição para a higiene pessoal
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
BR112018010830A2 (pt) cápsula de partícula de nicotina
BR112018012952A2 (pt) composições para higiene pessoal
BR112015015872A2 (pt) composição de tratamento oral
TR201901516T4 (tr) Nöroprotektif ajanlar ve bunların kullanımları.
BR112015028869A2 (pt) nanocápsula de emulsão dupla conjugada de anticorpo e métodos de preparação da mesma
BR102015006886B8 (pt) Composição tópicas que compreendem 4-hexilresorcinol e pós e uso
CL2018003587A1 (es) Composición de cal apagada en polvo altamente porosa.
BR112016010351A2 (pt) Composições em forma de pó, métodos de produção de uma composição em forma de pó, preparação farmacêutica, e artigo médico
BR112017004060A2 (pt) composição de ligante e formulação de tinta feita da mesma
BR112016028922A8 (pt) composição na forma de partículas compactadas e uso da mesma
BR112019006087A2 (pt) composição de cuidados bucais e método para beneficiar dentes de um indivíduo
BR112017011256A2 (pt) métodos de preparação de concentrado em suspensão (sc) de pesticida, concentrado em suspensão (sc) de pesticida, e método de semeadura de campo
BR112018068817A2 (pt) beta-caseínas e função cognitiva
BR112015000275A2 (pt) utilização de um extrato de mirta como agente anti-biopelícula face p. acnes

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO TWO LLC (US)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B25A Requested transfer of rights approved

Owner name: CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)